Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Gray hair regained color after thyroid hormone treatment.

Ayurveda-based care improved quality of life for breast cancer patients without serious side effects.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Hair loss needs more research for better treatments.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Aromatherapy uses essential oils to improve mood and well-being.

Using skin stem cells and certain molecules might lead to scar-free skin healing.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Ultrasound-assisted gene therapy could revolutionize tissue regeneration by improving gene delivery.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.